A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also raises concern about the accuracy and impact of such life-altering news. [Read more…] about Questionable “Alzheimer’s blood test” goes on sale prior to FDA approval
- An article on the role of neuroplasticity in Rep. Gabrielle Giffords’ recovery.
- A new study that used a blood test able to detect beta amyloid 42 (the protein fragment that makes up Alzheimer’s plaque) and suggested that the association between amyloid and cognitive decline could be modified by cognitive reserve.
- An article on a new brain scan technology to detect Alzheimer’s pathology in the brain.
- An article reporting the answer of Don Tapscott to the question “What scientific concept would improve everybody’s cognitive toolkit?” [Read more…] about Interesting Recent Studies and Articles on Neuroplasticity, Cognitive Reserve, and Brain Fitness